Literature DB >> 14501005

Effects of lipophilicity on the affinity and nonspecific binding of iodinated benzothiazole derivatives.

Yanming Wang1, Chester A Mathis, Guo-Feng Huang, Manik L Debnath, Daniel P Holt, Li Shao, William E Klunk.   

Abstract

Aseries of novel 2-aryl benzothiazole derivates substituted with iodine in different positions have been synthesized as amyloid-binding ligands. The affinity of these compounds for synthetic amyloid beta (1-40) (Abeta[1-40]) fibrils was determined. Introduction of the iodo group in the position ortho to an amino group increased the binding affinity, whereas the iodination ortho to a hydroxyl group decreased the binding affinity. Selected compounds with high binding affinity and moderate lipophilicity (logP values, 1.65-3.90) were radiolabeled and evaluated in normal mice for brain uptake and clearance. Structure-activity relationship (SAR) studies showed a strong correlation between the lipophilicity of the iodinated compounds and the binding affinity as well as nonspecific binding. As the lipophilicity increased, the affinity for Abeta(1-40) fibrils improved; however, nonspecific binding in mouse brain reflected by low brain clearance also increased with increasing lipophilicity. These results provide important SAR information to guide the development of novel amyloid-binding agents and provide further insights into the molecular interaction between 2-aryl benzothiazole ligands and Abeta fibrils.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14501005     DOI: 10.1385/JMN:20:3:255

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  17 in total

Review 1.  beta-peptide immunization: a possible new treatment for Alzheimer disease.

Authors:  D B Schenk; P Seubert; I Lieberburg; J Wallace
Journal:  Arch Neurol       Date:  2000-07

Review 2.  Progress towards testing the amyloid hypothesis: inhibitors of APP processing.

Authors:  R E Olson; R A Copeland; D Seiffert
Journal:  Curr Opin Drug Discov Devel       Date:  2001-07

3.  Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease.

Authors:  F Bard; C Cannon; R Barbour; R L Burke; D Games; H Grajeda; T Guido; K Hu; J Huang; K Johnson-Wood; K Khan; D Kholodenko; M Lee; I Lieberburg; R Motter; M Nguyen; F Soriano; N Vasquez; K Weiss; B Welch; P Seubert; D Schenk; T Yednock
Journal:  Nat Med       Date:  2000-08       Impact factor: 53.440

4.  Imaging Alzheimer's amyloid.

Authors:  D J Selkoe
Journal:  Nat Biotechnol       Date:  2000-08       Impact factor: 54.908

5.  Targeting alzheimer amyloid plaques in vivo.

Authors:  T M Wengenack; G L Curran; J F Poduslo
Journal:  Nat Biotechnol       Date:  2000-08       Impact factor: 54.908

6.  Relationship between lipophilicity and brain extraction of C-11-labeled radiopharmaceuticals.

Authors:  D D Dishino; M J Welch; M R Kilbourn; M E Raichle
Journal:  J Nucl Med       Date:  1983-11       Impact factor: 10.057

7.  A lipophilic thioflavin-T derivative for positron emission tomography (PET) imaging of amyloid in brain.

Authors:  Chester A Mathis; Brian J Bacskai; Stephen T Kajdasz; Megan E McLellan; Matthew P Frosch; Bradley T Hyman; Daniel P Holt; Yanming Wang; Guo-Feng Huang; Manik L Debnath; William E Klunk
Journal:  Bioorg Med Chem Lett       Date:  2002-02-11       Impact factor: 2.823

8.  Imaging Abeta plaques in living transgenic mice with multiphoton microscopy and methoxy-X04, a systemically administered Congo red derivative.

Authors:  William E Klunk; Brian J Bacskai; Chester A Mathis; Stephen T Kajdasz; Megan E McLellan; Matthew P Frosch; Manik L Debnath; Daniel P Holt; Yanming Wang; Bradley T Hyman
Journal:  J Neuropathol Exp Neurol       Date:  2002-09       Impact factor: 3.685

9.  Synthesis and evaluation of 2-(3'-iodo-4'-aminophenyl)-6-hydroxybenzothiazole for in vivo quantitation of amyloid deposits in Alzheimer's disease.

Authors:  Yanming Wang; William E Klunk; Guo-Feng Huang; Manik L Debnath; Daniel P Holt; Chester A Mathis
Journal:  J Mol Neurosci       Date:  2002 Aug-Oct       Impact factor: 3.444

10.  The binding of 2-(4'-methylaminophenyl)benzothiazole to postmortem brain homogenates is dominated by the amyloid component.

Authors:  William E Klunk; Yanming Wang; Guo-feng Huang; Manik L Debnath; Daniel P Holt; Li Shao; Ronald L Hamilton; Milos D Ikonomovic; Steven T DeKosky; Chester A Mathis
Journal:  J Neurosci       Date:  2003-03-15       Impact factor: 6.167

View more
  10 in total

1.  Drug discovery for Alzheimer's disease: the end of the beginning.

Authors:  Lorenzo M Refolo; Howard M Fillit
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 3.444

2.  Synthesis and biological evaluation studies of novel quinazolinone derivatives as antibacterial and anti-inflammatory agents.

Authors:  Mohamed F Zayed; Memy H Hassan
Journal:  Saudi Pharm J       Date:  2013-04-06       Impact factor: 4.330

Review 3.  Insight into amyloid structure using chemical probes.

Authors:  Ashley A Reinke; Jason E Gestwicki
Journal:  Chem Biol Drug Des       Date:  2011-04-26       Impact factor: 2.817

4.  Development of a PET/SPECT agent for amyloid imaging in Alzheimer's disease.

Authors:  Yanming Wang; William E Klunk; Manik L Debnath; Guo-Feng Huang; Daniel P Holt; Li Shao; Chester A Mathis
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 3.444

Review 5.  Smart optical probes for near-infrared fluorescence imaging of Alzheimer's disease pathology.

Authors:  Scott B Raymond; Jesse Skoch; Ivory D Hills; Evgueni E Nesterov; Timothy M Swager; Brian J Bacskai
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-03       Impact factor: 9.236

6.  Direct catalytic arylation of heteroarenes with meso-bromophenyl-substituted porphyrins.

Authors:  Alexei Nikolaevich Kiselev; Olga Konstantinovna Grigorova; Alexei Dmitrievich Averin; Sergei Aleksandrovich Syrbu; Oskar Iosifovich Koifman; Irina Petrovna Beletskaya
Journal:  Beilstein J Org Chem       Date:  2017-08-03       Impact factor: 2.883

7.  Salicylate metal-binding isosteres as fragments for metalloenzyme inhibition.

Authors:  Moritz K Jackl; Hyeonglim Seo; Johannes Karges; Mark Kalaj; Seth M Cohen
Journal:  Chem Sci       Date:  2022-01-21       Impact factor: 9.825

8.  Synthesis, antitumor activity, 3D-QSAR and molecular docking studies of new iodinated 4-(3H)-quinazolinones 3N-substituted.

Authors:  Marcia Pérez-Fehrmann; Víctor Kesternich; Arturo Puelles; Víctor Quezada; Fernanda Salazar; Philippe Christen; Jonathan Castillo; Juan Guillermo Cárcamo; Alejandro Castro-Alvarez; Ronald Nelson
Journal:  RSC Adv       Date:  2022-08-02       Impact factor: 4.036

9.  Amyloid-β probes: Review of structure-activity and brain-kinetics relationships.

Authors:  Todd J Eckroat; Abdelrahman S Mayhoub; Sylvie Garneau-Tsodikova
Journal:  Beilstein J Org Chem       Date:  2013-05-28       Impact factor: 2.883

10.  In vivo evaluation of the nitroimidazole-based thioflavin-T derivatives as cerebral ischemia markers.

Authors:  Taiwei Chu; Zejun Li; Xinqi Liu; Xiangyun Wang
Journal:  Int J Biomed Imaging       Date:  2007
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.